相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Viral vector strategies for investigating midbrain dopamine circuits underlying motivated behaviors
Daniel F. Cardozo Pinto et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
THE NEURAL UNDERPINNINGS OF COGNITIVE FLEXIBILITY AND THEIR DISRUPTION IN PSYCHOTIC ILLNESS
James A. Waltz
NEUROSCIENCE (2017)
Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders
Simon McCarthy-Jones et al.
PSYCHIATRY RESEARCH (2017)
Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia
Sara Lariviere et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2017)
Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study
Kristin R. Laurens et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2016)
The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders
John J. McGrath et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Circuit-Based Corticostriatal Homologies Between Rat and Primate
Sarah R. Heilbronner et al.
BIOLOGICAL PSYCHIATRY (2016)
Clozapine V. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities
James M. McNally et al.
CURRENT OPINION IN PSYCHIATRY (2016)
God has sent me to you: Right temporal epilepsy, left prefrontal psychosis
Shahar Arzy et al.
EPILEPSY & BEHAVIOR (2016)
Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats
Linde Boekhoudt et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
Ragy R. Girgis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
Anthony A. Grace
NATURE REVIEWS NEUROSCIENCE (2016)
Aging-Related Dysfunction of Striatal Cholinergic Interneurons Produces Conflict in Action Selection
Miriam Matamales et al.
NEURON (2016)
Hallucinations in adolescents and risk for mental disorders and suicidal behaviour in adulthood: Prospective evidence from the MUSP birth cohort study
Melissa Connell et al.
SCHIZOPHRENIA RESEARCH (2016)
Alterations in the hippocampus and thalamus in individuals at high risk for psychosis
Fabienne Harrisberger et al.
NPJ SCHIZOPHRENIA (2016)
DREADDs (Designer Receptors Exclusively Activated by Designer Drugs): Chemogenetic Tools with Therapeutic Utility
Daniel J. Urban et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Corticostriatal Control of Goal-Directed Action Is Impaired in Schizophrenia
Richard W. Morris et al.
BIOLOGICAL PSYCHIATRY (2015)
Psychotic Symptoms Associated with Left Caudate Infarction
Ying-Chih Cheng et al.
INTERNATIONAL JOURNAL OF GERONTOLOGY (2015)
Closing the translational gap between mutant mouse models and the clinical reality of psychotic illness
Colm M. O'Tuathaigh et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Clozapine and GABA transmission in schizophrenia disease models Establishing principles to guide treatments
William T. O'Connor et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The basal ganglia select the expected sensory input used for predictive coding
Brian Colder
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2015)
Effects of the D-1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder
Daniel R. Rosell et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Basal Ganglia Circuits for Reward Value-Guided Behavior
Okihide Hikosaka et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 37 (2014)
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Arsime Demjaha et al.
BIOLOGICAL PSYCHIATRY (2014)
Schizophrenia: from dopaminergic to glutamatergic interventions
Marc Laruelle
CURRENT OPINION IN PHARMACOLOGY (2014)
The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations
A. Amad et al.
MOLECULAR PSYCHIATRY (2014)
Direct and indirect pathways of basal ganglia: a critical reappraisal
Paolo Calabresi et al.
NATURE NEUROSCIENCE (2014)
Dopamine D2 Receptors Regulate the Anatomical and Functional Balance of Basal Ganglia Circuitry
Maxime Cazorla et al.
NEURON (2014)
Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
Marvin S. Swartz et al.
PSYCHIATRIC SERVICES (2014)
Prior Antipsychotic Drug Treatment Prevents Response to Novel Antipsychotic Agent in the Methylazoxymethanol Acetate Model of Schizophrenia
Kathryn M. Gill et al.
SCHIZOPHRENIA BULLETIN (2014)
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS
Neal R. Swerdlow et al.
SCHIZOPHRENIA RESEARCH (2014)
Dopaminergic basis of salience dysregulation in psychosis
Toby T. Winton-Brown et al.
TRENDS IN NEUROSCIENCES (2014)
Translational studies of goal-directed action as a framework for classifying deficits across psychiatric disorders
Kristi R. Griffiths et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2014)
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Alice Egerton et al.
BIOLOGICAL PSYCHIATRY (2013)
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
Oliver D. Howes et al.
BRAIN (2013)
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
Oswald J. N. Bloemen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
The development of delusion revisited: A transdiagnostic framework
Michele Poletti et al.
PSYCHIATRY RESEARCH (2013)
Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2013)
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2013)
Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
Sander V. Haijma et al.
SCHIZOPHRENIA BULLETIN (2013)
Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia
James P. Kesby et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: Support for the processing speed hypothesis
Ian Kelleher et al.
COGNITIVE NEUROPSYCHIATRY (2013)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development
Alice Egerton et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments
O. D. Howes et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Reversal learning as a measure of impulsive and compulsive behavior in addictions
Alicia Izquierdo et al.
PSYCHOPHARMACOLOGY (2012)
The Treatment of Hallucinations in Schizophrenia Spectrum Disorders
Iris E. C. Sommer et al.
SCHIZOPHRENIA BULLETIN (2012)
Contributions of the striatum to learning, motivation, and performance: an associative account
Mimi Liljeholm et al.
TRENDS IN COGNITIVE SCIENCES (2012)
Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models
D. Eyles et al.
TRANSLATIONAL PSYCHIATRY (2012)
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
P. Fusar-Poli et al.
MOLECULAR PSYCHIATRY (2011)
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
O. Howes et al.
MOLECULAR PSYCHIATRY (2011)
LESIONS OF THE DORSOMEDIAL STRIATUM DISRUPT PREPULSE INHIBITION
L. C. Baldan Ramsey et al.
NEUROSCIENCE (2011)
The association between general psychological distress and delusional-like experiences: A large population-based study
Sukanta Saha et al.
SCHIZOPHRENIA RESEARCH (2011)
Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study
Abraham Reichenberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis A Multimodal Imaging Study
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography
Lawrence S. Kegeles et al.
BIOLOGICAL PSYCHIATRY (2010)
Altered Relationship Between Hippocampal Glutamate Levels and Striatal Dopamine Function in Subjects at Ultra High Risk of Psychosis
James M. Stone et al.
BIOLOGICAL PSYCHIATRY (2010)
Dopaminergic Modulation of Cognitive Control: Distinct Roles for the Prefrontal Cortex and the Basal Ganglia
Martine van Schouwenburg et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Posterior dorsomedial striatum is critical for both selective instrumental and Pavlovian reward learning
Laura H. Corbit et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Human and Rodent Homologies in Action Control: Corticostriatal Determinants of Goal-Directed and Habitual Action
Bernard W. Balleine et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations
Ralf-Peter Behrendt
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm
William Perry et al.
PSYCHIATRY RESEARCH (2010)
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
Brooke M. Roberts et al.
PSYCHOPHARMACOLOGY (2010)
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Maarten van den Buuse
SCHIZOPHRENIA BULLETIN (2010)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naive Schizophrenic Subjects
Anissa Abi-Dargham et al.
BIOLOGICAL PSYCHIATRY (2009)
The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response
Aygun Ertugrul et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Altered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockade
Teresa Marie du Bois et al.
NEUROCHEMICAL RESEARCH (2008)
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia
Mark S. George et al.
SCHIZOPHRENIA RESEARCH (2007)
A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: Implications for the neuropathology of schizophrenia
Holly Moore et al.
BIOLOGICAL PSYCHIATRY (2006)
Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans
Y. Chudasama et al.
BIOLOGICAL PSYCHOLOGY (2006)
The role of the dorsomedial striatum in instrumental conditioning
HH Yin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Specific effects of an amnesic drug: Effect of lorazepam on study time allocation and on judgment of learning
M Izaute et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Modulation of the locomotor responses induced by D1-like and D2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens
HN David et al.
NEUROPHARMACOLOGY (2004)
Relationship of behavioural and symptomatic syndromes in schizophrenia to spatial working memory and attentional set-shifting ability
C Pantelis et al.
PSYCHOLOGICAL MEDICINE (2004)
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging
TEJ Behrens et al.
NATURE NEUROSCIENCE (2003)
Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia
S Kapur
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Error-related negativity and correct response negativity in schizophrenia
AT Bates et al.
CLINICAL NEUROPHYSIOLOGY (2002)
Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone - Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyphenylethyleneglycol and clinical evaluations
N Aymard et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
A Abi-Dargham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation
SA Castner et al.
SCIENCE (2000)
分享论文
